Nationwide multi-centric prospective study for the identification of biomarkers to predict the treatment responses of nivolumab through comprehensive analyses of pretreatment plasma exosome mRNAs from head and neck cancer patients (BIONEXT study).

Sato K, Toh S, Murakami T, Nakano T, Hongo T, Matsuo M, Hashimoto K, Sugasawa M, Yamazaki K, Ueki Y, Nakashima T, Uryu H, Ono T, Umeno H, Ueda T, Kano S, Tsukahara K, Watanabe A, Ota I, Monden N, Iwae S, Maruo T, Asada Y, Hanai N, Sano D, Ozawa H, Asakage T, Fukusumi T, Masuda M

Open source

DOI: 10.3389/fimmu.2024.1464419
Published: 2024
Container: Frontiers in immunology
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2024.1464419,
  title = {Nationwide multi-centric prospective study for the identification of biomarkers to predict the treatment responses of nivolumab through comprehensive analyses of pretreatment plasma exosome mRNAs from head and neck cancer patients (BIONEXT study).},
  author = {Sato K and Toh S and Murakami T and Nakano T and Hongo T and Matsuo M and Hashimoto K and Sugasawa M and Yamazaki K and Ueki Y and Nakashima T and Uryu H and Ono T and Umeno H and Ueda T and Kano S and Tsukahara K and Watanabe A and Ota I and Monden N and Iwae S and Maruo T and Asada Y and Hanai N and Sano D and Ozawa H and Asakage T and Fukusumi T and Masuda M},
  year = {2024},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2024.1464419},
  url = {https://doi.org/10.3389/fimmu.2024.1464419}
}

RIS

TY  - JOUR
TI  - Nationwide multi-centric prospective study for the identification of biomarkers to predict the treatment responses of nivolumab through comprehensive analyses of pretreatment plasma exosome mRNAs from head and neck cancer patients (BIONEXT study).
AU  - Sato K
AU  - Toh S
AU  - Murakami T
AU  - Nakano T
AU  - Hongo T
AU  - Matsuo M
AU  - Hashimoto K
AU  - Sugasawa M
AU  - Yamazaki K
AU  - Ueki Y
AU  - Nakashima T
AU  - Uryu H
AU  - Ono T
AU  - Umeno H
AU  - Ueda T
AU  - Kano S
AU  - Tsukahara K
AU  - Watanabe A
AU  - Ota I
AU  - Monden N
AU  - Iwae S
AU  - Maruo T
AU  - Asada Y
AU  - Hanai N
AU  - Sano D
AU  - Ozawa H
AU  - Asakage T
AU  - Fukusumi T
AU  - Masuda M
PY  - 2024
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2024.1464419
UR  - https://doi.org/10.3389/fimmu.2024.1464419
ER  -

APA

K, S., S, T., T, M., T, N., T, H., M, M., K, H., M, S., K, Y., Y, U., T, N., H, U., T, O., H, U., T, U., S, K., K, T., A, W., I, O., N, M., S, I., T, M., Y, A., N, H., D, S., H, O., T, A., T, F., & M, M. (2024). Nationwide multi-centric prospective study for the identification of biomarkers to predict the treatment responses of nivolumab through comprehensive analyses of pretreatment plasma exosome mRNAs from head and neck cancer patients (BIONEXT study).. Frontiers in immunology. https://doi.org/10.3389/fimmu.2024.1464419

Source records

pubmed · retrieved 2026-09-27T13:39:47.020Z
europe-pmc · retrieved 2026-09-27T13:39:47.033Z
doaj · retrieved 2026-09-27T13:39:47.017Z